Clinical trial
Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA
NCT01562665 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2012
- Completion date
- February 28, 2015
- Enrollment
- 25 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
non small cells lung cancer